Robert W. King
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Virology top 5%
- HIV Research and Treatment
Papers in
- Epidemiology 12
- Hepatitis B Virus Studies 9
- Liver Disease Diagnosis and Treatment 2
-
- HIV/AIDS drug development and treatment 8
- Co-authors
- Stephanie K. Ladner (6 shared papers)Michaël Otto (7 shared papers)Katie Zaifert (3 shared papers)Christopher S. Barker (1 shared paper)Christoph Seeger (1 shared paper)Ju‐Tao Guo (1 shared paper)Thomas Miller (3 shared papers)Robert B. Perni (2 shared papers)
- Journals
- Antiviral chemistry & chemotherapy (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Drug Resistance Updates (1 paper)Gastroenterology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Robert W. King
29 papers receiving 1.1k citations
Robert W. King's Hit Papers
Peers
Comparison fields: 5 of 87
- Hepatology 527
- Virology 157
- Epidemiology 778
- Infectious Diseases 308
- Agronomy and Crop Science 42
Countries citing papers authored by Robert W. King
This map shows the geographic impact of Robert W. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert W. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert W. King more than expected).
Fields of papers citing papers by Robert W. King
This network shows the impact of papers produced by Robert W. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert W. King. The network helps show where Robert W. King may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert W. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication Hit paper breakdown → | 1997 | 530 |
| 2 | 1998 | 127 | |
| 3 | 2000 | 69 | |
| 4 | The hepatitis B virus M539V polymerase variation responsible for 3TC resistance also confers cross-resistance to other nucleoside analogues. | 1998 | 53 |
| 5 | 2002 | 47 | |
| 6 | 1991 | 44 | |
| 7 | 1998 | 37 | |
| 8 | 2004 | 33 | |
| 9 | 1995 | 27 | |
| 10 | 1995 | 25 | |
| 11 | 1962 | 23 | |
| 12 | 2001 | 20 | |
| 13 | 1963 | 19 | |
| 14 | 2003 | 15 | |
| 15 | 2002 | 15 | |
| 16 | 1954 | 13 | |
| 17 | Dextranase in sugar production: factory experience. | 2000 | 13 |
| 18 | 2018 | 11 | |
| 19 | 1977 | 8 | |
| 20 | 2003 | 5 |
About Robert W. King
Robert W. King is a scholar working on Epidemiology, Infectious Diseases, Molecular Biology, Genetics and Virology, having authored 29 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), HIV/AIDS drug development and treatment (8 papers), Hepatitis C virus research (5 papers), HIV Research and Treatment (4 papers), Biochemical and Molecular Research (4 papers), Virus-based gene therapy research (4 papers), Liver Disease Diagnosis and Treatment (2 papers) and Vector-Borne Animal Diseases (2 papers). The work is most often cited by research in Hepatology (527 citations), Virology (157 citations), Epidemiology (778 citations), Infectious Diseases (308 citations) and Agronomy and Crop Science (42 citations). Robert W. King has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Stephanie K. Ladner, Michaël Otto, Katie Zaifert, Christopher S. Barker, Christoph Seeger, Ju‐Tao Guo, Thomas Miller, Robert B. Perni, Carol Reid and Ronald M. Klabe. Their work appears in journals such as Antiviral chemistry & chemotherapy, Antimicrobial Agents and Chemotherapy, Drug Resistance Updates, Gastroenterology and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.